# Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy

> **NCT07562841** · PHASE1 · RECRUITING · sponsor: **West China Hospital** · enrollment: 6 (estimated)

## Conditions studied

- Advanced Melanoma

## Interventions

- **DRUG:** Au-TMP
- **RADIATION:** Fractionated Radiotherapy (RT)
- **DRUG:** Toripalimab

## Key facts

- **NCT ID:** NCT07562841
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-28
- **Primary completion:** 2028-04-30
- **Final completion:** 2029-04-30
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07562841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07562841, "Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT07562841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*